Search results
Neurogene reports safe gene therapy trial for Rett syndrome By Investing.com
Investing.com· 2 hours agoNeurogene Inc. (NASDAQ: NGNE), a clinical-stage biotech company, has announced initial safety...
How the Medical Industry Could Produce the Biggest AI Stock Winners
InvestorPlace· 19 hours agoEditor’s note: “How the Medical Industry Could Produce the Biggest AI Stock Winners” was previously...
Your phone can tell when you’re depressed
Vox· 2 hours agoOver the last several years, academic researchers and startups have built AI-powered apps that use phones, smart watches, and social media to spot...
AI products for kids promising friendship and learning? 3 things to consider
The Conversation· 1 day agoThis is no doubt driven by rapid development in Artificial Intelligence, with impacts being widely felt. Companies are looking to enhance productivity and revenue, while governments are considering ...
Catch up on the day’s stories: When grief and AI collide, Social Security shortfall, benefits of...
CNN via Yahoo News· 16 hours agoLooking ahead ️ Tonight: Boeing is set to launch its Starliner capsule with two astronauts aboard,...
Errol Holmes and the healing power of massage therapy
Rolling Out· 21 hours agoIn this episode of Equity in Focus, host Kevin E. Hooks talks with Errol Holmes, a pioneer in...
BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 21 hours agoCompleting these investigations early in the first quarter gives a better understanding of the ease...
Study: Women can safely use hormone replacement therapy during menopause
UPI· 6 days agoHormone replacement therapy can safely ease middle-aged women's symptoms during early menopause,...
These Are The 5 Best Stocks To Buy And Watch Now
Investor's Business Daily· 5 days agoBuying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So which are the best stocks to buy now or put on a...
GlycoMimetics downgraded after Phase 3 trial fails to meet endpoint By Investing.com
Investing.com· 2 hours agoGlycoMimetics' uproleselan, a drug candidate for treating relapsed or refractory acute myeloid...